DFO
ARIA

Duquesne Family Office’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Duquesne Family Office’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,645,000
Closed -$8.88M – 52
2014
Q3 		$8.88M Buy
+1,645,000
New +$9.61M 1.09% 33

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Duquesne Family Office's ARIA Position: Q4 2014 in Review

Duquesne Family Office sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2014, closing a stake of 1,645,000 shares — an estimated $8.88M sold.

Duquesne Family Office first reported a position in ARIA in Q3 2014 and held it in 1 quarter. The position peaked at $8.88M in Q3 2014. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • Duquesne Family Office reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Duquesne Family Office sold 1,645,000 Ariad Pharmaceuticals Inc shares in Q4 2014, an estimated $8.88M.
  • Duquesne Family Office first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • Duquesne Family Office's Ariad Pharmaceuticals Inc position peaked at $8.88M in Q3 2014.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on Duquesne Family Office's 13F filing for Q4 2014, filed 12 Feb 2015.